Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2025

Genmab — Maj 2025

Planlagt Fastgjort Låst Flyttet Genmab
308 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #158

    maybe i should post the link for the more
    lazy people https://library.ehaweb.org/eha/#!*search=epcoritamab*browseby=8*listing=0*sortby=1

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #159

      EHA25 - EPCORE NHL-5 - Fixed-duration epcor + pola-R-CHP with follow-up of 16.1 mos in pts with newly diagnosed : ORR was 100% with 97% achieving a CR

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #160

        EHA25 - EPCORE NHL-2 -Epcor + R-ICE demonstrated high CR rates in pts with R/R DLBCL eligible for ASCT, most of whom were high risk, having progressed <12 mo of 1L tx. ORR was 87%; 20 pts (65%) had a CR and 7 (23%) a partial response (PR

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #161

          Til sammenligning til EPCORE NHL-2: Background:
          First-line (1L) standard of care (SOC) for diffuse large B-cell lymphoma (DLBCL) is rituximab plus C, H, vincristine, and P (R-CHOP), and it continues to evolve with pola-R-CHP showing higher complete response rates (CRR) of 78% and longer progression-free survival (PFS) than R-CHOP (Tilly 2022)

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #162

            Certainly looks good 🙂

            1 Reply Last reply
            0
            • L Offline
              L Offline
              lahn1
              wrote on sidst redigeret af
              #163

              Kun nået til de 3 første men EPCO i kombi ser ud til at være bedste valg

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #164

                Det er stort set altid tilfældet. Blot safety holder. Se hvor langt man er kommet i MM. Tæt på en “cure”

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #165

                  As said by EL - JNJ nightmare: https://finance.yahoo.com/news/halozyme-j-j-slide-analyst-150056315.html

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #166

                    Det er svært ikke at trække på smilebåndet 😄

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #167

                      Skadefryd er ikke at kimse af 🙂

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Plimsoller
                        wrote on sidst redigeret af
                        #168

                        Nu kommer deres lobbyister på overarbejde...

                        1 Reply Last reply
                        0
                        • R Offline
                          R Offline
                          Riis7
                          wrote on sidst redigeret af
                          #169

                          Link Preview Image
                          Healthcare worst-performing S&P 500 subsector year to date: Mizuho expert

                          Tariffs, executive orders, and FTC probes are just some of the problems piling up for the pharmaceutical industry. Trump's actions are pressuring a historically "safe" sector.

                          favicon

                          Yahoo Finance (finance.yahoo.com)

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bikube
                            wrote on sidst redigeret af
                            #170

                            Hvem var det, der sagde, at JnJ måske ombestemmer sig og alligevel vil have "Superdara" ?

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #171

                              Sundhedsaktierne i USA fortsatte nedturen - ikke længere sikker havn https://proinvestor.com/investornyt/1317372/sundhedsaktierne-i-usa-fortsatte-nedturen-ikke-laengere-sikker-havn

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #172

                                Should You Buy Johnson & Johnson Stock Now? https://proinvestor.com/investornyt/1317399/should-you-buy-johnson-amp-johnson-stock-now

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #173

                                  VIDEO: Response seen with Rina-S in ovarian cancer despite FR-alpha expression levels https://www.healio.com/news/hematology-oncology/20250514/video-response-seen-with-rina-s-in-ovarian-cancer-despite-fr-alpha-expression-levels

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #174

                                    Pharma-aktier er typisk dem, investorer regner for en sikker havn i urolige tider. Men ikke engang dén sektor er fredet længere, hvor Trump kommer med udmeldinger om told og store prissænkninger på medicin i USA. Hvad kan vi som investorer se frem mod? Hvornår slutter dette mareridt? Det giver Helge Larsen sit bud på. Herudover omtales Lundbecks flotte regnskab og Genmabs udsigt til evt. lidt mindre royalty på Darzalex i 2029. Kort video: https://proinvestor.com/boards/126377

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #175

                                      Genmab er dagens aktie hos Jyske https://www.jyskebank.dk/finansnyt/morgennyt/4088394a-a337-4c2b-83a7-9ec9553a07fe/!ut/p/z1/rVRLc5swEP4tPfiokUAEcG6AU8fBL_yokS4emShECRIOxiTur68w0ynxNHU6sS6rXe1--5j9BCmMIVWsEikrRa5YpnVC7fXU7FmGO0fj_tTHKFoMw--z3sxYTBz4AxIfkg4aDvx5BFfn3Kl-Rh8cD-l4es6F6BTOhyksA64qwV_hUuWF1A3Ma8RtIu4hsZDr4q7FAMPYAVZiboCLmQO6POleXWGGnAcOb89lCNHfMqyC0Tpa3sx07L6U64TJLROpgkTmRcqVOpTNg-T3Yi8h4ZKJrDHt8n2RcO2pLTteVEIr_1fzScHu9NZB9iiyLH8RGqZtfXEkJ_CT6AhvDPqhOcEmNi8Lfzpu-9LwAwvZwSBcOOMZsicXhne9

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        lahn1
                                        wrote on sidst redigeret af
                                        #176

                                        Igen ? 😄

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #177

                                          Det har den vel været jævnligt gennem det sidste halvandet års tid

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper